Inotiv Expands Protein/Peptide Bioanalytical Capabilities With This Deal

Contract research organization Inotiv Inc  (NASDAQ: NOTV ) acquired Nashville, Tennessee-based Protypia Inc  for $11 million . Inotiv specializes in nonclinical and analytical drug discovery, development services, research models, and related products and services. Protypia is a protein/peptide bioanalytical company offering high-quality, targeted tissue-based ... Full story available on